Brief: Adial Pharmaceuticals Inc - On August 31, Received Written Notice From Nasdaq Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard

Azora Therapeutics

02/09/2022 22:28

Sept 2 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS INC -  ON AUGUST 31, RECEIVED
WRITTEN
NOTICE FROM NASDAQ OF DELISTING OR FAILURE TO SATISFY A
CONTINUED LISTING RULE OR STANDARD

Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))